CK-30 600 mg (Compound K)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CK-30 600 mg (Compound K), covering 2017-05-02 to 2017-05-02. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Open-label, Two-way Crossover Study to Assess the Pharmacokinetics and Safety of CK-30 600 mg (Compound K) [NA]